Through high-throughput screening of 24 inhibitors on 12 colorectal cancer and three colorectal organoids in this organoid living biobank, adavivint was found to exhibit anti-tumor activity and low toxicity in colorectal organoids, independent of the canonical Wnt/β-catenin signaling.
[Advanced Science]